Selleckchem Inc

Bio Active Compounds.

Recent products

Emapalumab (anti-IFN?)

£243.00£2,432.00 / 340.203,404.80 Standard

Leronlimab (anti-CCR5)

£243.00£2,432.00 / 340.203,404.80 Standard

Isatuximab (anti-CD38)

£243.00£2,432.00 / 340.203,404.80 Standard

Dupilumab (anti-IL-4R?)

£243.00£2,432.00 / 340.203,404.80 Standard

Sabatolimab (anti-TIM-3)

£243.00£2,432.00 / 340.203,404.80 Standard

Magrolimab (anti-CD47)

£243.00£2,432.00 / 340.203,404.80 Standard

Sintilimab (anti-PD-1)

£243.00£2,432.00 / 340.203,404.80 Standard

Elotuzumab (anti-SLAMF7)

£243.00£2,432.00 / 340.203,404.80 Standard

Vibostolimab (anti-TIGIT)

£243.00£2,432.00 / 340.203,404.80 Standard

Brodalumab (anti-IL17RA)

£243.00£2,432.00 / 340.203,404.80 Standard

Sacituzumab (anti-Trop-2)

£243.00£2,432.00 / 340.203,404.80 Standard

Siltuximab (anti-IL-6)

£243.00£2,432.00 / 340.203,404.80 Standard

Relatlimab (anti-LAG-3)

£243.00£2,432.00 / 340.203,404.80 Standard

Tiragolumab (anti-TIGIT)

£243.00£2,432.00 / 340.203,404.80 Standard

Daratumumab (anti-CD38)

£243.00£2,432.00 / 340.203,404.80 Standard

Secukinumab (anti-IL-17A)

£243.00£2,432.00 / 340.203,404.80 Standard

1 702 703 704 705